NCT02315586View on ClinicalTrials.gov

Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis

CompletedOBSERVATIONAL
Enrollment

63

Participants

Timeline

Start Date

January 28, 2015

Primary Completion Date

November 2, 2016

Study Completion Date

February 23, 2022

Conditions
Idiopathic Pulmonary Fibrosis
Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT02315586 - Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis | Biotech Hunter | Biotech Hunter